< Back

ICF Awarded Over $40 Million In Contracts to Drive Health Innovation with Advanced Technology

December 11, 2024 at 4:05 PM EST
PDF Version

NIH Initiatives Will Enhance Generative AI Usage and Health Data Discoverability

RESTON, Va., Dec. 11, 2024 /PRNewswire/ -- ICF (NASDAQ:ICFI), a global consulting and digital services provider, has been awarded over $40 million in new and recompete contracts during the third quarter of 2024. The agreements span multiple National Institutes of Health (NIH) institutes and centers and will leverage ICF's cutting-edge technology and domain expertise to advance critical health programs.

Under these contracts, ICF will integrate its health, technical and scientific expertise with cloud and automated technologies, including generative AI and advanced analytics. These efforts will support IT and data modernization, software design and development, digital engagement, and research initiatives that help ensure improved health outcomes.

Key contract highlights include:

  • A new $11 million contract to support the National Library of Medicine's initiatives to advance generative AI projects, improve the discoverability of unprocessed materials and provide programming and technical support. The contract has a term of 30 months.
  • Additional single-award contract and subcontract agreements support the integration and modernization of biomedical and cancer research data systems, the improvement of overall IT operations, the deployment of Agile software development and design services and no-code AI-enabled query tools, and more. The combined value of the agreements totals nearly $20 million with terms ranging from one to five years.
  • A new $11 million subcontract with Banyan Communications, a small, women-owned communications agency, to provide the National Institute of Neurological Disorders and Stroke Information Resource Support Services a wide range of communication and digital engagement services through ICF Next, ICF's integrated, full-service digital and communications agency. The subcontract has a term of five years, including a one-year base and four one-year option periods.

"NIH plays a critical role in advancing medical research and driving innovations that lead to better health outcomes for people worldwide," said Jennifer Welham, ICF senior vice president for health, people and human services. "We are excited to bring our industry-leading health, technology and data science expertise to continue our longstanding partnership with NIH and drive meaningful improvements in health research, services and the collective body of scientific knowledge."

For over 50 years, ICF has supported health initiatives for nearly all major federal agencies, including numerous agencies and programs within the U.S. Department of Health and Human Services. The company's thousands of health professionals work hand in hand with thousands of technologists, data scientists and communicators to deliver mission-critical programs that improve health outcomes. At ICF Next, mission-driven strategists, marketers, technologists, communicators and data scientists help clients build next-level stakeholder engagement.

About ICF
ICF is a global consulting and technology services company with approximately 9,000 employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.

Caution Concerning Forward-looking Statements
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and various risks and uncertainties related to health epidemics, pandemics, and similar outbreaks. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements that are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.

Contact: Lauren Dyke, lauren.dyke@ICF.com, +1.571.373.5577

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/icf-awarded-over-40-million-in-contracts-to-drive-health-innovation-with-advanced-technology-302329241.html

SOURCE ICF

Subscribe to our investor news

* Required field

We’ll never share your email with anyone else

Some of the information on this Web site and the documents within it may contain forward-looking statements regarding future events or the future financial performance of the Company. Any forward-looking statement speaks only as of the date made. We undertake no obligation to update any forward-looking statements to reflect events or circumstances arising after the date on which they are made. We refer you to the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q on file with the U.S. Securities and Exchange Commission (SEC). These documents identify important factors that could cause the actual results to differ materially from those contained in our forward-looking statements.